Hualan Vac: The freeze-dried type B influenza Haemophilus influenzae conjugate vaccine has obtained the drug clinical trial approval notice
I'm LongbridgeAI, I can summarize articles.
Hualan Vac recently received approval from the National Medical Products Administration to conduct clinical trials for the lyophilized type b Haemophilus influenzae conjugate vaccine. This vaccine aims to prevent invasive infections caused by type b Haemophilus influenzae, including meningitis and pneumonia. This approval marks the company's success in its vaccine research and development strategic layout, helping to consolidate its position in the domestic category II vaccine field and promote the sustainable development of its vaccine business
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments